<?xml version='1.0' encoding='utf-8'?>
<section xmlns="https://code.dccouncil.us/schemas/dc-library" xmlns:codified="https://code.dccouncil.us/schemas/codified" xmlns:codify="https://code.dccouncil.us/schemas/codify" xmlns:xi="http://www.w3.org/2001/XInclude" containing-doc="D.C. Code">
  <num>48-843.02</num>
  <heading>Definitions.</heading>
  <text>For the purposes of this chapter, the term “pharmaceutical product” shall have the same meaning as provided in <cite path="§3-1201.02|(10A)|(B)|(iii)">§ 3-1201.02(10A)(B)(iii)</cite>.</text>
  <annotations>
    <annotation doc="D.C. Law 17-131" type="History" path="§402">Mar. 26, 2008, D.C. Law 17-131, § 402, 55 DCR 1659</annotation>
  </annotations>
</section>
